|Articles|July 14, 2016
Merck US Job Cuts "Likely to Affect About 300 Workers"
July 14, 2016
Advertisement
As it builds news research hubs in Massachusetts and California, Merck's job cuts in New Jersey and Pennsylvania are likely to affect about 300 workers,
Although the company is not currently providing a breakdown of the changes or specific numbers of impacted employees, a Merck spokesperson told Fortune: “[W]e anticipate that less than 10 percent of discovery, pre-clinical and early development colleagues will be impacted".
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
4
Marty Makary Out as FDA Commissioner: Report
5